[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366182-105":59,"doc-detail-366182-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","recent-insights-into-breast-cancer-volume-19-review-article-overview","Recent Insights Into Breast Cancer - Volume 19 - Review article overview","","Breast cancer remains the most prevalent malignant tumor and a leading cause of cancer-related mortality among women worldwide. The disease comprises distinct molecular subtypes that influence tumor behavior, metastatic potential, and therapeutic response. This review details recent advances, focusing on molecular and epigenetic mechanisms behind development, progression, and resistance. It highlights key signaling networks, epigenetic regulators and biomarkers, and how multigene panels and emerging therapies support diagnosis, prognosis, and precision treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/recent-insights-into-breast-cancer-volume-19-review-article-overview/366182/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/recent-insights-into-breast-cancer-volume-19-review-article-overview/366182.png","ImageObject",300,407,{"name":92,"@type":93},"Đào","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the review focus on regarding breast cancer?","Question",{"text":112,"@type":113},"The review emphasizes recent advances, particularly molecular and epigenetic mechanisms that drive tumor development, progression, and treatment resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which signaling pathways are highlighted as important in breast cancer?",{"text":117,"@type":113},"Key pathways include estrogen receptor (ER), HER2, Notch, FGFR, Wnt, and Hedgehog, described as essential for mammary stem cell regulation and oncogenesis.",{"name":119,"@type":110,"acceptedAnswer":120},"How are epigenetic changes connected to diagnosis and therapy?",{"text":121,"@type":113},"The review explains that DNA methylation, histone modifications, and microRNA expression shape gene activity relevant to tumor initiation and therapy resistance, and that epigenetic targets may support diagnosis, prognosis, and targeted treatment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366182,1791299500,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Recent Insights Into Breast Cancer: Molecular Pathways, Epigenetic Regulation, and Emerging Targeted Therapies  \nQuratulain Maqsood 1,2, Muhammad Umer Khan3,  \nTehreem Fatima2, Sania Khalid2 and Zaryab Ikram Malik2  \nBreast Cancer: Basic and Clinical Research  \nVolume 19: 1-20 © The Author(s) 2025 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/11782234251355663](DOI: 10.1177/11782234251355663)[ ](DOI: 10.1177/11782234251355663)[journals.sagepub.com/home/bcb](journals.sagepub.com/home/bcb)  \nAbstract  \nBreast cancer remains the most prevalent malignant tumor and a leading cause of cancer-related mortality among women worldwide. The disease comprises distinct molecular subtypes that influence tumor behavior, metastatic potential, and therapeutic response. This review presents recent advances in breast cancer research, with a particular emphasis on molecular and epigenetic mechanisms that contribute to tumor development, progression, and treatment resistance. Key signaling pathways—including estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), Notch, fibroblast growth factor receptor (FGFR), Wnt, and Hedgehog—play essential roles in the regulation of mammary stem cells and oncogenesis. Increasing evidence highlights the significance of epigenetic alterations such as DNA methylation, histone modifications, and microRNA expression in modulating gene activity relevant to tumor initiation and therapy resistance. Epigenetic molecular targets, including DNA methyltransferases (DNMTs), histone deacetylases (HDACs), EZH2, and non-coding RNAs, are gaining attention for their potential use in diagnosis, prognosis, and targeted therapy. Integration of multigene panel testing with epigenetic biomarkers has facilitated improved risk assessment and the development of individualized treatment strategies. Moreover, novel therapeutic approaches—such as CAR-T cell therapy, nanoparticle-mediated drug delivery systems, and the involvement of circular RNAs (circRNAs) in immune modulation—offer promising directions for precision medicine. This review consolidates current insights into the molecular and epigenetic landscape of breast cancer to provide a comprehensive understanding of disease complexity and to inform the development of more effective, personalized treatment options.  \nKeywords  \nBreast cancer, signaling, epigenetic, cancer treatment, pathogenesis  \nReceived: 29 September 2024; accepted: 10 June 2025  \nIntroduction  \nRecently, there has been a steady increase in the prevalence of breast cancer (BC) globally, especially in developed countries, with incidence rates of 1% and 99% in men and women, respectively. Globally, one in 7 women is likely to develop BC throughout their lives.1 Important risk factors for BC include hormonal contraception, excessive alcohol intake, inadequate diet, and excessive ultraviolet (UV) radiation exposure at an early age. Other risk factors include a history of ductal carcinoma, high body mass index, first delivery at a young age, nulliparity, relatively early menarche (before age 13), delayed menopause, and use of postmenopausal hormone treatment. In addition, it is hypothesized that both endogenous and exogenous factors, including aging, food, cigarette smoking, and UV exposure, whether individually or in combination, affect bodily  \ntissues and increase the risk of cancer development. Notably, BC-related morbidity and mortality vary considerably across geographical locations. For example, women with stable weight and large mammary tissue are at a higher risk than others among nulliparous hormone therapy  \n1 Department of Food Science, Institute of Agricultural Sciences, University of the Punjab, Lahore, Pakistan  \n2Centre for Applied Molecular Biology, University of the Punjab, Lahore, Pakistan  \n3Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan ","cbCaiuGJUv6awgTy","https://ap.wps.com/l/cbCaiuGJUv6awgTy","pdf",1023265,"English","# Abstract\n# Introduction\n# Breast cancer research overview\n## Molecular pathways and signaling networks\n## Epigenetic regulation and targets\n## Emerging targeted therapies","[{\"question\":\"What does the review focus on regarding breast cancer?\",\"answer\":\"The review emphasizes recent advances, particularly molecular and epigenetic mechanisms that drive tumor development, progression, and treatment resistance.\"},{\"question\":\"Which signaling pathways are highlighted as important in breast cancer?\",\"answer\":\"Key pathways include estrogen receptor (ER), HER2, Notch, FGFR, Wnt, and Hedgehog, described as essential for mammary stem cell regulation and oncogenesis.\"},{\"question\":\"How are epigenetic changes connected to diagnosis and therapy?\",\"answer\":\"The review explains that DNA methylation, histone modifications, and microRNA expression shape gene activity relevant to tumor initiation and therapy resistance, and that epigenetic targets may support diagnosis, prognosis, and targeted treatment.\"}]","Recent Insights Into Breast Cancer - Volume 19 - Review article overview | PDF",1790164107,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a301a72046fb9696687ce24363973888.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0e3ac63a8a00da98999947ecc6fb97a.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af915bb90c3dba5d84058e6994732691.webp",981,1387,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18fea9844e2002f765b911ea1119e2a0.webp",980,1385]